PTEN and breast cancer: In a patient-derived xenograft model of basal-like breast cancer, there was synergistic effect of MK-2206 and ridaforolimus on tumor growth and cell proliferation.39 PTEN knockdown increased this synergy suggesting a rationale to use this combination in basal-like breast cancer with PTEN loss.